Home/Rare Diseases/Short Bowel Syndrome

Gastrointestinal

Short Bowel Syndrome

Also called SBS, Short Gut Syndrome

Short Bowel Syndrome results from loss of sufficient small intestinal length or function, typically defined as less than 150-200 cm of functioning small bowel (normal is 300-600 cm). The loss of absorptive surface area leads to malabsorption of water, electrolytes, nutrients, and medications.

View active trialsMatch me to a trial

About Short Bowel Syndrome

Short Bowel Syndrome results from loss of sufficient small intestinal length or function, typically defined as less than 150-200 cm of functioning small bowel (normal is 300-600 cm). The loss of absorptive surface area leads to malabsorption of water, electrolytes, nutrients, and medications. The severity depends on the length and location of remaining bowel (duodenum and jejunum preferentially absorb certain nutrients and are more crucial than ileum), whether the colon is present (colonic presence improves prognosis), and intestinal adaptation. After resection, the remaining bowel undergoes adaptive changes over months to years, including increased absorptive capacity per unit length through villous elongation and mucosal thickening. However, adaptation has limits. Most patients become parenteral nutrition-dependent, with associated complications including central line infections, cholestasis (liver disease), and thrombosis. Quality of life is significantly impacted by dependence on intravenous nutrition, dietary restrictions, and chronic diarrhea. Intestinal bacterial overgrowth frequently complicates Short Bowel Syndrome. Some patients can eventually achieve nutritional independence through dietary modifications, medications (antiperislatics), and supportive measures.

Common Symptoms

  • Chronic severe diarrhea
  • Malabsorption with nutrient deficiencies
  • Abdominal pain and cramping
  • Nausea and loss of appetite
  • Steatorrhea (fatty, foul-smelling stools)
  • Weight loss and failure to thrive in children

Who It Affects

Short Bowel Syndrome results from surgical resection (most commonly due to Crohn's disease, mesenteric ischemia, trauma, or surgical complications) or congenital conditions. It can develop at any age, in both children and adults. In children, congenital short bowel from small intestinal atresia or gastroschisis is the primary cause. In adults, disease-related resection (Crohn's disease) or vascular events (mesenteric infarction) predominate. Long-term outcomes depend on the length and location of remaining bowel.

Getting Involved in Clinical Trials

Clinical trials for Short Bowel Syndrome focus on promoting intestinal adaptation and reducing parenteral nutrition dependence. Growth hormone therapy, glutamine supplementation, and pharmacologic agents have shown benefits. Trials investigate teduglutide (glucagon-like peptide 2 analog), which has FDA approval and promotes intestinal mucosal growth. Newer approaches including stem cell therapy and intestinal transplantation are being refined. Management requires coordination with specialized centers experienced in parenteral nutrition and Short Bowel Syndrome. Patients should consult with gastroenterologists specializing in this condition.

Trusted Sources

Active Clinical Trials for Short Bowel Syndrome

Finding trials for Short Bowel Syndrome...

Related Gastrointestinal Conditions

Gastrointestinal

Eosinophilic Esophagitis

Eosinophilic Esophagitis is a rare allergic/immune-mediated inflammatory disease of the esophagus characterized by eosin...

Gastrointestinal

Primary Biliary Cholangitis

Primary Biliary Cholangitis (PBC) is a chronic autoimmune liver disease in which the immune system mistakenly attacks th...

Gastrointestinal

Autoimmune Hepatitis

Autoimmune Hepatitis (AIH) is a chronic liver disease characterized by persistent inflammation and progressive fibrosis ...